fig1
From: Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance
![Heterotypic signaling of cancer-associated fibroblasts in shaping the cancer cell drug resistance](https://image.oaes.cc/81bfc658-3983-42b1-975a-2b50b004219c/5552.fig.1.jpg)
Figure 1. Origin and heterogeneity of cancer-associated fibroblasts. CAFs in the tumor microenvironment can be originated from MSCs, fibroblasts, adipocytes, pericytes, smooth muscle, endothelial and epithelial cells through the different trans-differentiation programs. Varieties of CAF subsets have been identified in cancer types of different tissue origins. The different subsets of CAFs show different functions and molecular features. CAF-S1 to CAF-S4 subsets are present in breast cancer. myCAF, iCAF and apCAF subsets are observed in PDAC. Several cancers exhibit overlapping populations of CAF subsets.